Helius Medical Technologies, Inc. (HSDT)
USD 0.38
(-6.0%)
USD 0.38
(-6.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.34 Million USD | -41.53% |
| 2022 | 9.13 Million USD | 221.01% |
| 2021 | 2.84 Million USD | 6.35% |
| 2020 | 2.67 Million USD | -40.69% |
| 2019 | 4.51 Million USD | -74.9% |
| 2018 | 17.97 Million USD | 25.69% |
| 2017 | 14.29 Million USD | 107.41% |
| 2016 | 6.89 Million USD | 148.05% |
| 2015 | 2.77 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.5 Million USD | -33.52% |
| 2024 Q1 | 3.77 Million USD | -29.41% |
| 2023 FY | 5.34 Million USD | -41.53% |
| 2023 Q2 | 6.18 Million USD | -19.6% |
| 2023 Q1 | 7.68 Million USD | -15.85% |
| 2023 Q3 | 5.83 Million USD | -5.63% |
| 2023 Q4 | 5.34 Million USD | -8.42% |
| 2022 Q3 | 5.89 Million USD | 188.55% |
| 2022 Q1 | 2.48 Million USD | -12.58% |
| 2022 FY | 9.13 Million USD | 221.01% |
| 2022 Q4 | 9.13 Million USD | 54.9% |
| 2022 Q2 | 2.04 Million USD | -17.85% |
| 2021 Q2 | 2.35 Million USD | -15.04% |
| 2021 Q3 | 2.84 Million USD | 20.94% |
| 2021 Q1 | 2.76 Million USD | 3.36% |
| 2021 FY | 2.84 Million USD | 6.35% |
| 2021 Q4 | 2.84 Million USD | 0.14% |
| 2020 FY | 2.67 Million USD | -40.69% |
| 2020 Q1 | 3.25 Million USD | -27.93% |
| 2020 Q2 | 2.3 Million USD | -29.03% |
| 2020 Q4 | 2.67 Million USD | -5.41% |
| 2020 Q3 | 2.82 Million USD | 22.57% |
| 2019 Q2 | 5.41 Million USD | -48.33% |
| 2019 Q1 | 10.48 Million USD | -41.69% |
| 2019 FY | 4.51 Million USD | -74.9% |
| 2019 Q4 | 4.51 Million USD | 11.19% |
| 2019 Q3 | 4.05 Million USD | -25.06% |
| 2018 Q3 | 17.76 Million USD | -39.02% |
| 2018 Q4 | 17.97 Million USD | 1.15% |
| 2018 FY | 17.97 Million USD | 25.69% |
| 2018 Q2 | 29.13 Million USD | 269.21% |
| 2018 Q1 | 7.89 Million USD | -44.81% |
| 2017 Q4 | 14.29 Million USD | 2.85% |
| 2017 FY | 14.29 Million USD | 107.41% |
| 2017 Q3 | 13.9 Million USD | 69.82% |
| 2017 Q2 | 8.18 Million USD | -13.89% |
| 2017 Q1 | 9.5 Million USD | 37.92% |
| 2016 Q2 | 4.34 Million USD | 6.98% |
| 2016 Q1 | 4.05 Million USD | -44.0% |
| 2016 FY | 6.89 Million USD | 148.05% |
| 2016 Q4 | 6.89 Million USD | 54.53% |
| 2016 Q3 | 4.46 Million USD | 2.79% |
| 2015 Q2 | 3.42 Million USD | 23.4% |
| 2015 Q1 | 2.77 Million USD | 129.64% |
| 2015 Q4 | 7.24 Million USD | 297.22% |
| 2015 FY | 2.77 Million USD | 0.0% |
| 2015 Q3 | 1.82 Million USD | -46.83% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | 1.16 Million USD | 36.1% |
| 2014 Q4 | 1.21 Million USD | 3.55% |
| 2014 Q1 | 583.94 Thousand USD | 0.0% |
| 2014 Q2 | 858.78 Thousand USD | 47.07% |
| 2013 Q2 | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 89.577% |
| BrainsWay Ltd. | 15.31 Million USD | 65.117% |
| Cerus Corporation | 144.3 Million USD | 96.298% |
| Envoy Medical, Inc. | 9.4 Million USD | 43.182% |
| electroCore, Inc. | 8.94 Million USD | 40.279% |
| IceCure Medical Ltd | 4.24 Million USD | -25.783% |
| Inogen, Inc. | 121.38 Million USD | 95.599% |
| OrthoPediatrics Corp. | 72.56 Million USD | 92.638% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 81.941% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -67.885% |
| MaxCyte, Inc. | 36.1 Million USD | 85.205% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -189.083% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1156.111% |
| Orthofix Medical Inc. | 326.58 Million USD | 98.364% |
| PAVmed Inc | 57.13 Million USD | 90.651% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 79.021% |
| RxSight, Inc. | 22.18 Million USD | 75.924% |
| Sight Sciences, Inc. | 46.43 Million USD | 88.496% |
| SI-BONE, Inc. | 61.05 Million USD | 91.25% |
| TELA Bio, Inc. | 59.16 Million USD | 90.971% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 95.313% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 48.231% |
| Acutus Medical, Inc. | 54.83 Million USD | 90.259% |
| Talis Biomedical Corporation | 29.22 Million USD | 81.721% |
| Spectral AI, Inc. | 12.4 Million USD | 56.923% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 76.908% |
| CVRx, Inc. | 39.28 Million USD | 86.401% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 55.327% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -119.899% |
| Bioventus Inc. | 589.79 Million USD | 99.094% |
| Venus Concept Inc. | 107.1 Million USD | 95.012% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 89.66% |
| LivaNova PLC | 1.15 Billion USD | 99.536% |
| 908 Devices Inc. | 37.49 Million USD | 85.751% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.241% |
| Nemaura Medical Inc. | 26.37 Million USD | 79.748% |
| NeuroPace, Inc. | 86.99 Million USD | 93.86% |
| LENSAR, Inc. | 22.4 Million USD | 76.161% |
| Apyx Medical Corporation | 52.31 Million USD | 89.789% |
| Cutera, Inc. | 518.12 Million USD | 98.969% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 81.785% |
| BioSig Technologies, Inc. | 4.68 Million USD | -14.023% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 90.848% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 75.14% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.757% |
| Axonics, Inc. | 82.35 Million USD | 93.514% |
| Outset Medical, Inc. | 190.91 Million USD | 97.202% |
| IRIDEX Corporation | 24.91 Million USD | 78.558% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 95.691% |
| IRadimed Corporation | 20.73 Million USD | 74.238% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -219.116% |
| INVO Bioscience, Inc. | 19.99 Million USD | 73.283% |
| Telesis Bio, Inc. | 40.87 Million USD | 86.93% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 86.904% |
| Varex Imaging Corporation | 668.6 Million USD | 99.201% |
| Quipt Home Medical Corp. | 136.29 Million USD | 96.081% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -49.552% |
| Pulmonx Corporation | 60.63 Million USD | 91.19% |
| Dynatronics Corporation | 11.78 Million USD | 54.652% |
| Modular Medical, Inc. | 2.27 Million USD | -135.123% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -31.447% |
| Semler Scientific, Inc. | 6.27 Million USD | 14.801% |
| InMode Ltd. | 75.91 Million USD | 92.963% |
| Bruker Corporation | 2.83 Billion USD | 99.812% |
| Cytosorbents Corporation | 29.98 Million USD | 82.185% |
| DexCom, Inc. | 4.19 Billion USD | 99.873% |
| Align Technology, Inc. | 2.45 Billion USD | 99.782% |
| Viveve Medical, Inc. | 10.84 Million USD | 50.751% |
| ZimVie Inc. | 795.85 Million USD | 99.329% |
| Movano Inc. | 5.97 Million USD | 10.549% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 94.893% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1156.111% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 55.327% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.164% |
| Profound Medical Corp. | 12.66 Million USD | 57.824% |
| Insulet Corporation | 1.85 Billion USD | 99.712% |
| enVVeno Medical Corporation | 2.43 Million USD | -119.384% |
| Surmodics, Inc. | 65.82 Million USD | 91.884% |
| iCAD, Inc. | 8 Million USD | 33.233% |
| Nuwellis, Inc. | 6.78 Million USD | 21.209% |
| Biotricity, Inc. | 35.91 Million USD | 85.128% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 97.605% |
| Aethlon Medical, Inc. | 2.47 Million USD | -115.434% |
| InspireMD, Inc. | 8.14 Million USD | 34.39% |
| PAVmed Inc. | 57.13 Million USD | 90.651% |
| BIOLASE, Inc. | 35.34 Million USD | 84.887% |
| Beyond Air, Inc. | 29.77 Million USD | 82.059% |
| FONAR Corporation | 57.45 Million USD | 90.703% |
| AxoGen, Inc. | 101.16 Million USD | 94.719% |
| Vivani Medical, Inc. | 25.03 Million USD | 78.663% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 93.915% |
| Inari Medical, Inc. | 209.32 Million USD | 97.448% |
| UFP Technologies, Inc. | 118.04 Million USD | 95.475% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 57.905% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -144.394% |
| Tenon Medical, Inc. | 5.56 Million USD | 4.042% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -200.281% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 69.706% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.831% |
| Sintx Technologies, Inc. | 6.59 Million USD | 18.975% |
| NanoVibronix, Inc. | 2.68 Million USD | -98.883% |
| Quanterix Corporation | 78.08 Million USD | 93.159% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -49.552% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -9.355% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.489% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.061% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 67.977% |
| NeuroMetrix, Inc. | 1.33 Million USD | -300.713% |
| Hyperfine, Inc. | 9.8 Million USD | 45.49% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 97.865% |
| Biomerica, Inc. | 2.66 Million USD | -100.601% |
| Bone Biologics Corporation | 831.4 Thousand USD | -542.529% |
| AVITA Medical, Inc. | 19.86 Million USD | 73.109% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -170.661% |
| Silk Road Medical, Inc | 114.15 Million USD | 95.321% |